View Post

First Adjuvant Treatment for Non-Small Cell Lung Cancer Approved

In COVID-19, Latest News by Precision Vaccinations

The U.S. Food and Drug Administration (FDA) announced the approval of Tagrisso (osimertinib) as the first adjuvant treatment for patients with non-small cell lung cancer whose tumors have a specific type of genetic mutation.
In the overall clinical trial population, patients who received Tagrisso had an 80 percent decrease in disease recurrence chance compared with patients who received a placebo, stated the FDA.

View Post

U.S. FDA Issues Emergency Authorization for Second COVID-19 Vaccine

In COVID-19, Latest News by Precision Vaccinations

The U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for the Moderna COVID-19 Vaccine for distribution in the USA for use in individuals 18 years of age and older.
The Moderna COVID-19 Vaccine (mRNA-1273) contains messenger RNA (mRNA), which is genetic material. 
Announced on December 18, 2020, this is the second FDA authorization of an experimental vaccine to prevent COVID-19.

View Post

Fewest Flu-Related Hospitalizations in Nine Years

In COVID-19, Latest News by Precision Vaccinations

The seasonal influenza activity remained lower than usual for this time of year, said the U.S. Centers for Disease Control and Prevention (CDC).
The CDC also reported the number of influenza-associated hospitalizations is lower than normal for this time of year and is ‘comparable to counts last seen during the 2011-12 season.’
And the CDC’s new weekly report (#50) confirmed since September 27, 2020, only (0.2%) of virus species tested were found infected with influenza. Of those found, 56.9 percent were identified as Influenza A.

View Post

Fewest Flu-Related Hospitalizations in Nine Years

In Influenza Vaccine News by Influenza Vaccine

The seasonal influenza activity remained lower than usual for this time of year, said the U.S. Centers for Disease Control and Prevention (CDC).
The CDC also reported the number of influenza-associated hospitalizations is lower than normal for this time of year and is ‘comparable to counts last seen during the 2011-12 season.’
And the CDC’s new weekly report (#50) confirmed since September 27, 2020, only (0.2%) of virus species tested were found infected with influenza. Of those found, 56.9 percent were identified as Influenza A.

View Post

Fewest Flu-Related Hospitalizations Reported in Nine Years

In COVID-19, Latest News by Precision Vaccinations

Seasonal influenza activity in the USA remains lower than usual for this time of year, says the U.S. Centers for Disease Control and Prevention (CDC).
The CDC also reported the number of influenza-associated hospitalizations is lower than average for this point in the 2020-2021 flu season and are ‘comparable to counts seen at this point during the 2011-12 season.’
And the CDC’s new weekly report (#50) confirmed since September 27, 2020, only (0.2%) of virus species tested were found infected with influenza. Of those found, 56.9 percent were identified as Influenza A.

View Post

Fewest Flu-Related Hospitalizations Reported in Nine Years

In Influenza Vaccine News by Influenza Vaccine

Seasonal influenza activity in the USA remains lower than usual for this time of year, says the U.S. Centers for Disease Control and Prevention (CDC).
The CDC also reported the number of influenza-associated hospitalizations is lower than average for this point in the 2020-2021 flu season and are ‘comparable to counts seen at this point during the 2011-12 season.’
And the CDC’s new weekly report (#50) confirmed since September 27, 2020, only (0.2%) of virus species tested were found infected with influenza. Of those found, 56.9 percent were identified as Influenza A.